On Air Now

Current Show

Jerry Bader   8:30 AM - 11:00 AM

Text "JBSHOW" to 79489 and get updates from me. Email me at: jerrybadershow@mwcradio.com

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1360 AM Northeast, WI 97.5 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
67° Feels Like: 67°
Wind: ESE 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 75°

Tonight

Partly Cloudy 56°

Tomorrow

Cloudy 70°

Alerts

J&J's prostate cancer drug approved in EU

LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.

The decision was expected after European regulators endorsed the treatment in July. J&J's Janssen unit has European rights for the product. Zytiga, or abiraterone, works by blocking the synthesis of testosterone, which can fuel cancer growth.

Abiraterone was developed by researchers at the Institute of Cancer Research and London's Royal Marsden Hospital, and British pharmaceutical firm BTG will receive an undisclosed milestone payment following the approval together with a royalty on worldwide sales.

The medicine was approved in the United States in May.

Comments